Efficacy and Safety of Cadonilimab in Combination with Pulocimab and Paclitaxel As Second-Line Therapy in Patients with Advanced Gastric or Gastroesophageal Junction (G/GEJ) Cancer Who Failed Immunochemotherapy: A Multicenter, Double-Blind, Randomized Trial.
JOURNAL OF CLINICAL ONCOLOGY(2024)
AI 理解论文
溯源树
样例
生成溯源树,研究论文发展脉络
Chat Paper
正在生成论文摘要